There are 2789 resources available
1702P - Primary endpoints of phase III trials for older patients with cancer
Presenter: Tomonori MIZUTANI
Session: ePoster Display
1700P - Functional status in older patients with lung and thoracic cancer
Presenter: Anne-Laure Couderc
Session: ePoster Display
1662P - Comprehensive analysis of the metabolic enzymes in patients with small cell lung cancer using a large-scale targeted proteomics assay
Presenter: Gouji Toyokawa
Session: ePoster Display
1663P - Prognostic impact of baseline neutrophil-to-lymphocyte ratio (NLR) and its change during treatment for overall survival in advanced SCLC
Presenter: MASASHI ISHIHARA
Session: ePoster Display
1619P - Transition to a virtual cancer multidisciplinary team meeting during the COVID-19 pandemic: Experience from a regional Irish Cancer Centre
Presenter: Caitriona Goggin
Session: ePoster Display
1620P - COVID-19 vaccines and cancer: Tailored information for Australia’s diverse populations
Presenter: Vivienne Milch
Session: ePoster Display
1531P - Multi-omic characterization of dedifferentiated liposarcoma: Towards a new model of oncogenesis?
Presenter: Sarah Watson
Session: ePoster Display
1470P - Oral azacitidine (CC-486) in patients with resected pancreatic adenocarcinoma at high risk for recurrence
Presenter: Thatcher Heumann
Session: ePoster Display
1361TiP - Trastuzumab deruxtecan (T-DXd) in patients (pts) with HER2-mutated (HER2m) metastatic non-small cell lung cancer (NSCLC): A phase (ph) II study (DESTINY-Lung02)
Presenter: Egbert F. Smit
Session: ePoster Display
1362TiP - Capmatinib versus docetaxel in pretreated patients with MET exon 14 skipping-mutated locally advanced or metastatic NSCLC: The GeoMETry-III phase III study
Presenter: Pierre-Jean Souquet
Session: ePoster Display